l-mind trial in relapsed/refractory dlbcl
Published 4 years ago • 1K plays • Length 6:37Download video MP4
Download video MP3
Similar videos
-
2:24
results of the l-mind trial in r/r dlbcl
-
1:22
dr. burke on the ongoing first-mind trial with tafasitamab in dlbcl
-
3:05
emerging treatments for relapsed/refractory dlbcl
-
1:32
dr. kahl on findings from the l-mind study with tafasitamab in dlbcl
-
1:16
dr. flinn on the utility of tafasitamab in relapsed/refractory dlbcl
-
5:32
relapsed/refractory dlbcl: unmet needs
-
6:05
l-mind study: r/r dlbcl
-
3:16
cd19-targeted mabs in relapsed/refractory dlbcl
-
2:50
tafasitamab-lenalidomide in r/r dlbcl: clinical trial results and real-world data
-
4:31
using novel therapy in relapsed-refractory dlbcl
-
1:35
long-term follow-up of tafasitamab and lenalidomide in r/r dlbcl
-
4:49
ash 2014: phase ii/iii study of lenalidomide in relapsed/refractory diffuse large b-cell lymphoma
-
1:01
dr. ritchie on the rationale of the aim trial in relapsed/refractory mantle cell lymphoma
-
1:20:47
practice-changing data in relapsed/refractory diffuse large b-cell lymphoma
-
1:36
the use of tafasitamab and lenalidomide in r/r dlbcl
-
5:51
re-mind versus l-mind regimen
-
1:31
long-term outcomes with tafasitamab plus lenalidomide for r/r dlbcl
-
4:09
novel treatment combinations for r/r dlbcl
-
21:56
what's new in the approach to dlbcl upfront and in the relapsed setting beyond car t